These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28473626)

  • 1. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.
    Harper L; Bouwman F; Burton EJ; Barkhof F; Scheltens P; O'Brien JT; Fox NC; Ridgway GR; Schott JM
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):908-916. PubMed ID: 28473626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-wise deviations from healthy aging for the detection of region-specific atrophy.
    Klöppel S; Yang S; Kellner E; Reisert M; Heimbach B; Urbach H; Linn J; Weidauer S; Andres T; Bröse M; Lahr J; Lützen N; Meyer PT; Peter J; Abdulkadir A; Hellwig S; Egger K;
    Neuroimage Clin; 2018; 20():851-860. PubMed ID: 30278372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
    Bejanin A; Murray ME; Martin P; Botha H; Tosakulwong N; Schwarz CG; Senjem ML; Chételat G; Kantarci K; Jack CR; Boeve BF; Knopman DS; Petersen RC; Giannini C; Parisi JE; Dickson DW; Whitwell JL; Josephs KA
    Brain; 2019 Nov; 142(11):3621-3635. PubMed ID: 31562527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease.
    Caso F; Agosta F; Scamarcia PG; Basaia S; Canu E; Magnani G; Volontè MA; Filippi M
    Parkinsonism Relat Disord; 2021 Oct; 91():154-161. PubMed ID: 34628194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of white matter tract pathology in frontotemporal dementia.
    Mahoney CJ; Ridgway GR; Malone IB; Downey LE; Beck J; Kinnunen KM; Schmitz N; Golden HL; Rohrer JD; Schott JM; Rossor MN; Ourselin S; Mead S; Fox NC; Warren JD
    Hum Brain Mapp; 2014 Aug; 35(8):4163-79. PubMed ID: 24510641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.
    Irwin DJ; McMillan CT; Xie SX; Rascovsky K; Van Deerlin VM; Coslett HB; Hamilton R; Aguirre GK; Lee EB; Lee VMY; Trojanowski JQ; Grossman M
    Brain; 2018 Jan; 141(1):288-301. PubMed ID: 29228211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
    Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
    Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.
    Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease.
    Blanc F; Colloby SJ; Cretin B; de Sousa PL; Demuynck C; O'Brien JT; Martin-Hunyadi C; McKeith I; Philippi N; Taylor JP
    Alzheimers Res Ther; 2016 Jul; 8():31. PubMed ID: 27484179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated voxel- and region-based analysis of gray matter and cerebrospinal fluid space in primary dementia disorders.
    Egger K; Rau A; Yang S; Klöppel S; Abdulkadir A; Kellner E; Frings L; Hellwig S; Urbach H;
    Brain Res; 2020 Jul; 1739():146800. PubMed ID: 32213295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.
    Harper L; Fumagalli GG; Barkhof F; Scheltens P; O'Brien JT; Bouwman F; Burton EJ; Rohrer JD; Fox NC; Ridgway GR; Schott JM
    Brain; 2016 Apr; 139(Pt 4):1211-25. PubMed ID: 26936938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
    van der Zande JJ; Steenwijk MD; Ten Kate M; Wattjes MP; Scheltens P; Lemstra AW
    Neurobiol Aging; 2018 Nov; 71():171-178. PubMed ID: 30149288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct white matter injury associated with medial temporal lobe atrophy in Alzheimer's versus semantic dementia.
    Bejanin A; Desgranges B; La Joie R; Landeau B; Perrotin A; Mézenge F; Belliard S; de La Sayette V; Eustache F; Chételat G
    Hum Brain Mapp; 2017 Apr; 38(4):1791-1800. PubMed ID: 27981671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.
    Andreotti J; Dierks T; Wahlund LO; Grieder M
    J Alzheimers Dis; 2017; 55(3):981-993. PubMed ID: 27802229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.